Strata Critical Medical, Inc.
SRTA- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001779128
In the last 90 days, Strata Critical Medical, Inc. insiders filed 1 open-market purchase and 0 sales; 140 institutions reported holding it in 13F filings for Q2 2026, worth $293.3M in total; superinvestors Third Point and ARK Invest hold it.
Key figures
- Market capClose on Nov 11, 2026
- $536.8M
- Insider buysLast 90 days, $10.0K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +15 vs. previous quarter
- 140
- 13F valueReported value at the end of Q2 2026
- $293.3M
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $197.1M
- −20.7% year over year
- Net income, FY2025
- $41.3M
- No comparable prior period
- Free cash flow, FY2025
- -$58.5M
- No comparable prior period
- Revenue, Q3 FY2026
- $74.1M
- +50.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net income for FY2025: $41.3M (21.0% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.55M
- Shares sold short
- Change
- +12.2K
- +0.3% vs. previous
- Days to cover
- 4.98
- At average daily volume
Superinvestors holding SRTA, Q2 2026
Go to the superinvestors tab2 superinvestors report holding Strata Critical Medical, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Third Point
Daniel Loeb
0.6%
Strata Critical Medical, Inc.'s share of the portfolio
- Shares
- 5,000,000
- Value
- $26.4M
ARK Invest
Cathie Wood
0.1%
Strata Critical Medical, Inc.'s share of the portfolio
- Shares
- 2,730,855
- Value
- $14.4M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Strata Critical Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 (view filing)8:57 AM ET | Nov 5 | 4 days | Lauck AndrewDirector | PPurchaseClass A common stock, $0.0001 par value per share | +2.00K | $5.00 | +$10.0K | +1.2%172.9K after | |
| Aug 13, 2026 (view filing)5:33 PM ET | Aug 10 | 3 daysLate | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −5.09K | $5.75 | −$29.3K | −3.4%146.5K after | |
| May 26, 2026 (view filing) | May 21-22 | 5 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −50.9K | $5.89 | −$299.4K | −25.2%151.3K after | 2 lots10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −14.3K | $5.79 | −$82.8K | −6.6%202.1K after | 10b5-1 |
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Heyburn William A.Co-CEO and CFO | PPurchaseClass A common stock, $0.0001 par value per share | +17.0K | $4.47 | +$76.0K | +1.2%1.40M after | |
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Lauck AndrewDirector | PPurchaseClass A common stock, $0.0001 par value per share | +5.00K | $4.37 | +$21.9K | +3.8%135.6K after | |
| Nov 24, 2025 (view filing) | Nov 20 | 4 days | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −11.0K | $4.37 | −$48.1K | −8.8%113.9K after | |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −11.0K | $4.31 | −$47.4K | −8.1%124.9K after | |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −48.0K | $4.94 | −$237.1K | −4.0%1.15M after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −46.9K | $4.94 | −$231.8K | −3.4%1.34M after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 140 holdersThe largest institutional positions in Strata Critical Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Third Point LLCSuperinvestorThird Point | 5,000,000 | $26.4M | 0.57% | 00.0% | Unchanged |
| Northern Right Capital Management, L.P. | 4,890,584 | $25.8M | 7.65% | +800,415+19.6% | Added |
| BlackRock, Inc. | 4,835,516 | $25.5M | 0.00% | +267,248+5.9% | Added |
| Royce & Associates LP | 3,132,933 | $16.5M | 0.13% | +316,561+11.2% | Added |
| Vanguard Capital Management LLC | 2,885,319 | $15.2M | 0.00% | +12,873+0.4% | Added |
| AWM Investment Company, Inc. | 2,821,468 | $14.9M | 1.29% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,730,855 | $14.4M | 0.09% | −4,724,429−63.4% | Reduced |
| First Eagle Investment Management, LLC | 2,314,614 | $12.2M | 0.02% | +48,371+2.1% | Added |
| Hurricane Capital Advisors LLC | 2,260,771 | $11.9M | 3.36% | +175,000+8.4% | Added |
| Pillsbury Lake Capital LLC | 2,171,006 | $11.4M | 3.14% | −432,790−16.6% | Reduced |
Holders of 5% or more of SRTA
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Strata Critical Medical, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Steele ExpCo Holdings, LLC | 13G/A | 9.00%7.92M shares | – | Jan 24, 20223 filings | Aug 20, 2026 | SEC |
| Third Point LLCSuperinvestorThird Point | 13D | 5.80%5.13M shares | 0.00 ppfrom 5.80% | Aug 11, 20253 filings | Oct 15, 2026 | SEC |
| Northern Right Capital Management, L.P. | 13G | 5.10%4.40M shares | New | Jun 17, 20261 filing | Jun 17, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.10%4.38M shares | +0.14 ppfrom 4.96% | Apr 25, 20254 filings | Jan 21, 2026 | SEC |